Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07489560

Evaluation of the Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft vs Standard of Care in the Treatment of Partial Thickness Thermal Burns

A Prospective, Multicenter, Randomized, Controlled Clinical Investigation Evaluating the Safety and Efficacy of Dehydrated Human Amnion-Intermediate-Chorion Membrane (dHAICM) Allograft vs Standard of Care in the Treatment of Partial Thickness Thermal Burns

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Cellution Biologics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the efficacy of a dehydrated human placental tissue product, commercially labeled as AmCoreMatrix Burn ™ versus SOC in the closure of partial thickness burns. Human Cellular and Tissue based Products (HCT/Ps), specifically Dehydrated Human Amnion - Intermediate Layer - Chorion Membrane (dHAICM) offer a multimodal biological approach to burn management. Unlike synthetic dressings or silver-based creams, dHAICM serves as a sophisticated bioactive scaffold. It is a minimally manipulated allograft that provides superior tensile strength and barrier function compared to single-layer membranes. This study aims to document its performance in hospital burn units.

Conditions

Interventions

TypeNameDescription
OTHERAmnion-Intermediate-ChorionDehydrated human placental multilayer allograft derived from donated human tissue. AIC contains amnion and chorion layers as well as basement membrane and trophoblast.
PROCEDUREStandard of Care (SOC)Standard of care is to establish a clean, healthy wound bed and optimize the wound environment to have the best chance of healing the wound. This is achieved through wound cleansing, debridement, offloading and moisture balance.

Timeline

Start date
2026-06-01
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2026-03-24
Last updated
2026-03-24

Source: ClinicalTrials.gov record NCT07489560. Inclusion in this directory is not an endorsement.